TABLE 2.

Correlation between CCL14 expression, clinicopathological characteristics, and patient overall survival.

Clinicopathological characteristics	Univariate analysis				Multivariate analysis
	HR	p >|z|	95% CI		HR	p >|z|	95% CI
CCL14 in cancer cells
High vs. low	1.836	0.032*	1.054	3.197	5.823	0.007*	1.605	21.130
CCL14 in stromal cells
High vs. low	1.668	0.040*	1.023	2.719	0.398	0.103	0.131	1.204
Age (years)
≤60 vs. > 60	1.253	0.386	0.753	2.083
Gender
Male vs. female	0.869	0.618	0.499	1.511
Lauren’s type
Intestinal vs. diffuse + mixed	1.193	0.640	0.569	2.504
Differentiation
Well and middle vs. poor	0.916	0.749	0.533	1.572	1.432	0.439	0.577	3.557
HER-2
Strong vs. middle vs. weak vs. negative	0.949	0.717	0.715	1.260
Preoperative CA199
≤37 vs. > 37	4.426	0.001*	1.907	10.274	7.230	0.002*	2.111	24.754
T
Tis–1 vs. 2 vs. 3 vs. 4	2.298	<0.001*	1.483	3.561
N
N0 vs. N1 vs. N2 vs. N3	2.719	<0.001*	1.635	2.904
M
M0 vs. M1	8.847	<0.001*	3.679	21.274
TNM stage
0–I vs. II vs. III–IV	2.739	<0.001*	1.909	3.928	3.993	<0.001*	2.166	7.359

*p < 0.05.